Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFD Technologies Regulatory News (FDP)

  • This share is currently suspended. It was suspended at a price of 2,450.00
  • There is currently no data for FDP

Re Contract

9 Jul 2008 07:00

RNS Number : 6296Y
First Derivatives PLC
09 July 2008
 

9 July 2008

First Derivatives plc 

(AIM:FDP.L, IEX:GYQ.I)

Software License Sale

The Board of First Derivatives plc ("First Derivatives" or the "Company") is pleased to announce that it has signed its first global contract for its qAlgo algorithmic trading product The sale is to a major financial institution operating in LondonNew York and Asia. The transaction includes both a substantial initial payment for implementation and an annually renewable license fee. 

The Company has made a major investment in developing a suite of trading, risk, CEP and market data focussed software. qAlgo, which represents just one product in the suite, was launched last year and has been well received.  This sale validates First Derivatives' strategy of developing its own branded products for the financial services market.

Commenting on the contract win, Michael ONeill, Chief Operating Officer Company said: "First Derivatives is at the forefront of the development and implementation of algorithmic trading systems. We have built an excellent reputation through our consulting services, customised application development and successful implementations of third party software but now we can supplement this business with our own suite of software.  The Board is very pleased to have secured its first global contract win of qAlgo.  We anticipate announcing further progress in the coming weeks as the Company is continuing to experience an encouraging level of enquiries in all areas of our business."

Contact:

First Derivatives plc

Brian Conlon

Tel: +44 (0)28 3025 2242

Charles Stanley Securities

Nominated Adviser

Russell Cook/Carl Holmes

Tel: +44 (0)20 7149 6000

Goodbody Corporate Finance 

IEX Adviser

Diane Hodgson/Linda Hickey

Tel: +353 1 667 0420

Stakeholder Communications 

Carl Whyte 

Lisa Nugent

Tel: +44 (0)28 9033 9949

Tel: +44 (0) 20 7903 5148

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTUUUPUMUPRGMR
Date   Source Headline
2nd Feb 20229:33 amRNSHolding(s) in Company
20th Jan 20227:00 amRNSDirectorate Change
17th Jan 20227:00 amRNSDirector/PDMR Shareholding
31st Dec 202110:10 amRNSTotal Voting Rights
13th Dec 20212:59 pmRNSIssue of Equity
9th Dec 20219:40 amRNSDirector/PDMR Shareholding
1st Dec 20211:55 pmRNSHolding(s) in Company
30th Nov 202110:52 amRNSTotal Voting Rights
18th Nov 20217:00 amRNSAppointment of Adviser
15th Nov 20215:12 pmRNSIssue of Equity
9th Nov 20218:48 amRNSHolding(s) in Company
2nd Nov 20217:00 amRNSResults for the six months ended 31 August 2021
11th Oct 20217:00 amRNSHolding(s) in Company
6th Oct 20214:27 pmRNSHolding(s) in Company
6th Oct 20217:00 amRNSNotice of Results
1st Sep 20219:29 amRNSTotal Voting Rights
25th Aug 20215:37 pmRNSIssue of Equity
11th Aug 20217:00 amRNSLTIP Award
30th Jul 20217:00 amRNSDirectorate Change
8th Jul 20215:23 pmRNSResult of AGM
2nd Jul 202111:47 amRNSHolding(s) in Company
30th Jun 202112:16 pmRNSTotal Voting Rights
22nd Jun 20215:44 pmRNSIssue of Equity
15th Jun 20211:20 pmRNSHolding(s) in Company
14th Jun 20215:05 pmRNSHolding(s) in Company
8th Jun 20215:19 pmRNSNotice of AGM & Change of Name
1st Jun 202110:31 amRNSTotal Voting Rights
26th May 20214:06 pmRNSHolding(s) in Company
25th May 20216:08 pmRNSIssue of Equity
18th May 20217:00 amRNSFull Year Results
13th Apr 20217:00 amRNSTrading Update
31st Mar 202110:29 amRNSTotal Voting Rights
3rd Mar 20216:13 pmRNSHolding(s) in Company
1st Mar 20217:00 amRNSAppointment of Scott Matthews as CEO for MRP
1st Mar 20217:00 amRNSAppointment of Eric Raab as KX CTO
26th Feb 20214:18 pmRNSIssue of Equity
26th Feb 20219:25 amRNSTotal Voting Rights
23rd Feb 20217:00 amRNSPartial sale of Quantile Technologies holding
15th Feb 20214:28 pmRNSIssue of Equity
29th Jan 20219:59 amRNSTotal Voting Rights
25th Jan 20216:18 pmRNSIssue of Equity
31st Dec 202011:17 amRNSTotal Voting Rights
9th Dec 20207:00 amRNSDirectorate Change
8th Dec 202012:46 pmRNSIssue of Equity
30th Nov 20209:35 amRNSTotal Voting Rights
16th Nov 20203:21 pmRNSHolding(s) in Company
13th Nov 20204:08 pmRNSHolding(s) in Company
12th Nov 20207:00 amRNSResult of secondary placing
30th Oct 20201:30 pmRNSIssue of Equity
27th Oct 20207:00 amRNSInterim results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.